Imperial College London
Portrait Picture

DrVictoriaMale

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Senior Lecturer in Reproductive Immunology
 
 
 
//

Contact

 

v.male

 
 
//

Location

 

Chelsea and Westminster HospitalChelsea and Westminster Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Male:2022:10.1038/s41577-022-00703-6,
author = {Male, V},
doi = {10.1038/s41577-022-00703-6},
journal = {Nature Reviews Immunology},
pages = {277--282},
title = {SARS-CoV-2 infection and COVID-19 vaccination in pregnancy},
url = {http://dx.doi.org/10.1038/s41577-022-00703-6},
volume = {22},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - SARS-CoV-2 infection poses increased risks of poor outcomes during pregnancy, including preterm birth and stillbirth. There is also developing concern over the effects of SARS-CoV-2 infection on the placenta, and these effects seem to vary between different viral variants. Despite these risks, many pregnant individuals have been reluctant to be vaccinated against the virus owing to safety concerns. We now have extensive data confirming the safety and effectiveness of COVID-19 vaccination during pregnancy, although it will also be necessary to determine the effectiveness of these vaccines specifically against newly emerging viral variants, including Omicron. In this Progress article, I cover recent developments in our understanding of the risks of SARS-CoV-2 infection in pregnancy, and how vaccination can reduce these.
AU  - Male,V
DO  - 10.1038/s41577-022-00703-6
EP  - 282
PY  - 2022///
SN  - 1474-1733
SP  - 277
TI  - SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
T2  - Nature Reviews Immunology
UR  - http://dx.doi.org/10.1038/s41577-022-00703-6
UR  - https://www.ncbi.nlm.nih.gov/pubmed/35304596
UR  - https://www.nature.com/articles/s41577-022-00703-6
UR  - http://hdl.handle.net/10044/1/96011
VL  - 22
ER  -
Download